# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1037322 | B | Inhibition of human liver FBPase 1 | Homo sapiens | 50 | assay format | Scientific Literature | ||
2. | ALA1037323 | B | Inhibition of rat liver FBPase 1 | Rattus norvegicus | 45 | assay format | Scientific Literature | ||
3. | ALA1037324 | F | Inhibition of glucose production in rat primary hepatocytes | Rattus norvegicus | 46 | cell-based format | Scientific Literature | ||
4. | ALA1037325 | F | Reduction of blood glucose level in 18 hrs fasted normal Sprague-Dawley rat at 10 mg/kg, iv after 1 hr interval | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
5. | ALA1037326 | B | Inhibition of adenosine kinase AMP binding site | 1 | single protein format | Scientific Literature | |||
6. | ALA1037327 | B | Inhibition of adenylate kinase AMP binding site | 1 | assay format | Scientific Literature | |||
7. | ALA1037328 | B | Inhibition of AMP deaminase AMP binding site | 1 | single protein format | Scientific Literature | |||
8. | ALA1037329 | B | Inhibition of glycogen phosphorylase AMP binding site | 1 | assay format | Scientific Literature | |||
9. | ALA1037330 | B | Inhibition of phosphofructokinase AMP binding site | 1 | single protein format | Scientific Literature | |||
10. | ALA1040008 | B | Displacement of [3H]AMP from human liver FBPase 1 | Homo sapiens | 1 | assay format | Scientific Literature | ||
11. | ALA1040009 | F | Inhibition of glucose production in rat primary hepatocytes at 10 uM | Rattus norvegicus | 1 | cell-based format | Scientific Literature | ||
12. | ALA1040010 | F | Inhibition of glucose production in rat primary hepatocytes at 100 uM | Rattus norvegicus | 1 | cell-based format | Scientific Literature | ||
13. | ALA1040011 | F | Reduction of blood glucose level in 5 hrs fasted ZDF rat at 10 mg/kg, iv administered every 1 hr for 6 hrs | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
14. | ALA1040012 | A | Oral bioavailability in 18 hrs fasted normal Sprague-Dawley rat up to 100 mg/kg by urinary excretion assay | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
15. | ALA1657811 | B | Inhibition of human liver FBP | Homo sapiens | 73 | assay format | Scientific Literature | ||
16. | ALA1657813 | A | Half life in Sprague-Dawley rat | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
17. | ALA1657814 | A | Clearance in Sprague-Dawley rat | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
18. | ALA1657815 | A | Volume of distribution in Sprague-Dawley rat | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
19. | ALA1657816 | A | Plasma protein binding in Sprague-Dawley rat | Rattus norvegicus | 2 | cell-free format | Scientific Literature | ||
20. | ALA1657817 | A | Plasma protein binding in human | Homo sapiens | 2 | cell-free format | Scientific Literature |